Skip to main content
ROIV logo

ROIV · Roivant Sciences Ltd. · Analyst Estimates

Track ROIV — free
$35.50 +0.00 (+0.00%) At close · Oct 2
Market Cap
$25.86B
Shares
722.32M
Volume · Oct 2 4.39M Avg daily vol (3M) 7.01M

Analyst Estimates

Compare analyst forecasts for Roivant Sciences Ltd. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-24 10:03 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2027-03-31

Analyst estimates for FY ending 2027-03-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.96131
-1.58044
-1.23
—
-1.58044
-1.49573
-1.58044
-1.49573
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
3
3
0
0
Revenue
USD
Publication date not stated
13905640
52100310
91400000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

FY ending 2028-03-31

Analyst estimates for FY ending 2028-03-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.10317
-1.71772
-1.27
—
-1.71772
-1.55935
-1.71772
-1.55935
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
2
2
1
1
Revenue
USD
Publication date not stated
119000000
409464490
637260000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.59143
-0.45048
-0.35
—
-0.45048
-0.39663
-0.45048
-0.39663
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
3
3
0
0
Revenue
USD
Publication date not stated
0
3709090
8000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.52764
-0.41255
-0.35
—
-0.41255
-0.36502
-0.41255
-0.36502
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
3
3
0
0
Revenue
USD
Publication date not stated
0
12295450
27000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —
Key facts CIK 1635088 CUSIP G76279101 13F (30d) 11 filings 11 filers Visit website Investor relations